Various hypotheses have been proposed. Mechanical pressure from the silicone oil may result in ischemia, said Lihteh Wu, M,.D., at the American Society of Retinal Specialists.
For decades, slicone oil tamponade during the procedure to treat a detached retina, which if left untreated or treated unsuccessfully can lead to blindness. Silicone oil has several characteristics that make it an excellent substance for holding the retina in place and preventing damaging leaks of fluid, and it is left in the eye for some time while the retina heals. However, there is also a long-recognized risk of vision loss, albeit it small, associated with silicone of tamponade.
In a presentation at the American Society of Retina Specialists on Friday Lihteh Wu, M.D. , a U.S.-trained retinal specialist who lives and practices in Costa Rica, reviewed the research on silicone oil tamponade and discussed the rise and falls of various hypotheses about the reasons occurs. Tamponade is a medical term for closing or blocking a wound or body cavity by — or as if by— a tampon, which has come to mean an absorbent vaginal insert to prevent menstrual bleeding but can refer to anything that that closes a wound or blocks bleeding.
In a brief interview after his presentation, Wu said in most retinal specialists prefer to use gas in uncomplicated cases of retinal detachment. “The thing with gas is that gas disappears spontaneously. The oil stays here until you’re pretty much sure the retina heals in place,” he said.
Wu said one hypothesis that didn’t pan out was that silicone oil disrupted the ability of Müller cells to siphon off potassium ions into the vitreous so the ions accumulated in the subretinal space. Another resulted in the creation of charged potassium ions that damage the eye. Another theory that fell by the wayside is that the silicone oil resulted in transmission of high-energy blue light, particularly in aphakic eyes.
Although it is not a completely settled issue, Wu said the explanation for vision loss from silicone oil tamponade that currently seems most plausible is the oil causes some pressure that results in ischemia. Retinal specialists don’t need to stop using silicone oil tamponade but should be careful about leaving the oil in the eye too long.
“Whenever you feel that the oil has accomplish what it needs to, just take it out. Don't leave it longer than you need to,” Wu said.
It Flopped on Primary Endpoint, But Succeeded on Visual Acuity | ASRS 2023
July 31st 2023AXNOO7, an investigational agent for geographic atrophy, did not affect geographic atrophy lesions but showed positive effects of tests of visual acuity. A novel, neuroprotective mechanism of action may be why.
Read More
When a Biosimilar Might Increase Not Decrease Costs | Ravi Parikh, M.D., M.P.H., ASRS 2023
July 30th 2023The approval of an ophthalmic bevacizumab biosimilar might mean the end of low-cost, repackaged Avastin as an anti-VEGF treatment for retinal diseases, with the unintended consequence of adding $457 million to Medicare B spending.
Read More
Endophthalmitis After Anti-VEGF Injections: A Rare But Real Risk | ASRS 2023
July 30th 2023Researchers used the American Academy of Ophthalmology's IRIS database to quantify the risk of endophthalmitis — inflammation of intraocular fluids — after injections with anti-VEGF drugs. They found that post-injection endophthalmitis occurs, on average, once every 3,500 injections.
Read More
Eylea Biosimilar Produces Favorable Results in a Switching Study | ASRS 2023
July 30th 2023Samsung Bioepsis' SB15 was comparable to Eylea (aflibercept) in a 56-week randomized clinical trial that included a rerandomization at 32 weeks. The rerandomization resulted in 111 study volunteers switching from Eylea to the biosimilar for the last part of the study.
Read More
The Long and Short (Interval Switch) of the PULSAR Trial | ASRS 2023
July 29th 2023About 20% of patients in the trial of a high-dose, longer-interval regimen of Eylea (aflibercept )switched to shorter intervals, according to data presented today at the American Society of Retinal Specialists annual scientific meeting, which is being held in Seattle. Researchers didn't find any clues as to why in their baseline characteristics.
Read More